Literature DB >> 11432505

Newborn PKU screening in Turkey: at present and organization for future.

I Ozalp1, T Coşkun, A Tokatli, H S Kalkanoğlu, A Dursun, S Tokol, G Köksal, M Ozgüc, R Köse.   

Abstract

At present, pkenylketonuria screening is a national child health program in Turkey which is carried out collaboratively by the Ministry of Health and three University Children's Hospitals in Ankara, Istanbul and Izmir. Since 1986 the number of cities included in the screening program has gradually increased, now and it covers all the metropolises the country. A total of 383 babies were found with persistent hyperphenylalaninemia (1:4,172) among 1,605,582 babies screened by the Guthrie test at the Hacettepe Screening Center in Ankara. By taking into account pretreatment phenylalanine levels and phenlyalanine tolerances at five years of age, the numbers of classical and mild-moderate phenylketonuria and mild hyperphenylalaninemia cases were 216, 102 and 58, respectively. The major problems encountered in the screening program and in management of the detected cases were unsatisfactory sample collection, early discharge from maternity hospitals, difficulties in reaching some detected cases, and noncompliance with dietary therapy due to illiterate parents or to lack of social insurance. To screen and treat all newborns for phenylketonuria and to include at least hypothyroidism in the screening program, there is a need for a more disciplinary intersectoral approach than exists at present.

Entities:  

Mesh:

Year:  2001        PMID: 11432505

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  18 in total

1.  The development and organization of newborn screening programs in Turkey.

Authors:  Başak Tezel; Dilek Dilli; Hilal Bolat; Hatice Sahman; Sema Ozbaş; Deniz Acıcan; Mustafa Ertek; Mehmet Rıfat Köse; Uğur Dilmen
Journal:  J Clin Lab Anal       Date:  2013-12-27       Impact factor: 2.352

Review 2.  Current situation and prospects of newborn screening and treatment for Phenylketonuria in China - compared with the current situation in the United States, UK and Japan.

Authors:  Lin Mei; Peipei Song; Norihiro Kokudo; Lingzhong Xu; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2013-11

3.  A child with phenylketonuria and focal segmental glomerulosclerosis, the bright side of proteinuria.

Authors:  Fatma Rabah; Khalid Al-Thihli; Mohamed El-Naggari; Ibtisam B Elnour
Journal:  Metab Brain Dis       Date:  2017-04-07       Impact factor: 3.584

4.  Maternal phenylketonuria in Turkey: outcomes of 71 pregnancies and issues in management.

Authors:  Yılmaz Yıldız; Hatice Serap Sivri
Journal:  Eur J Pediatr       Date:  2019-05-03       Impact factor: 3.183

5.  Genetic screening services provided in Turkey.

Authors:  Yurdagül Erdem; Fulya Tekşen
Journal:  J Genet Couns       Date:  2013-09-18       Impact factor: 2.537

Review 6.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

7.  Does maternal knowledge impact blood phenylalanine concentration in Turkish children with phenylketonuria?

Authors:  H Gokmen Ozel; T Kucukkasap; G Koksal; H S Kalkanoglu Sivri; A Dursun; A Tokatli; T Coskun
Journal:  J Inherit Metab Dis       Date:  2008-06-27       Impact factor: 4.982

Review 8.  Phenylketonuria: translating research into novel therapies.

Authors:  Gladys Ho; John Christodoulou
Journal:  Transl Pediatr       Date:  2014-04

9.  Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis.

Authors:  Pamela K Foreman; Andrea V Margulis; Kimberly Alexander; Renee Shediac; Brian Calingaert; Abenah Harding; Manel Pladevall-Vila; Sarah Landis
Journal:  Orphanet J Rare Dis       Date:  2021-06-03       Impact factor: 4.123

10.  Tetrahydrobiopterin deficiencies: Lesson from clinical experience.

Authors:  Ayse Ergul Bozaci; Esra Er; Havva Yazici; Ebru Canda; Sema Kalkan Uçar; Merve Güvenc Saka; Cenk Eraslan; Hüseyin Onay; Sara Habif; Beat Thöny; Mahmut Coker
Journal:  JIMD Rep       Date:  2021-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.